What is Kura Oncology's PP&E (net)?

Kura Oncology (KURA) reported PP&E (net) of $7.61M in Q1 2026.

How has Kura Oncology's PP&E (net) changed year-over-year?

Kura Oncology's PP&E (net) increased by 224.2% year-over-year, from $2.35M to $7.61M.

What is the long-term trend for Kura Oncology's PP&E (net)?

Over 5 years (2020 to 2025), Kura Oncology's PP&E (net) has grown at a 31.2% compound annual growth rate (CAGR), from $2.02M to $7.86M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Kura Oncology KURA PP&E (Net)

PP&E (Net) at other companies

Johnson & JohnsonJNJ

$23.27B+11.5%

AmgenAMGN

$8.22B+23.0%

ExelixisEXEL

$95.52M-17.0%

Syndax PharmaceuticalsSNDX

$177K—

AbbVieABBV

$5.69B+8.6%

Corvus PharmaceuticalsCRVS

$282K+70.9%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's PP&E (net)?: Kura Oncology (KURA) reported PP&E (net) of $7.61M in Q1 2026.
How has Kura Oncology's PP&E (net) changed year-over-year?: Kura Oncology's PP&E (net) increased by 224.2% year-over-year, from $2.35M to $7.61M.
What is the long-term trend for Kura Oncology's PP&E (net)?: Over 5 years (2020 to 2025), Kura Oncology's PP&E (net) has grown at a 31.2% compound annual growth rate (CAGR), from $2.02M to $7.86M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.